Centiva Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-128,544
Closed -$5.06M – 2266
2023
Q2
$5.06M Buy
+128,544
New +$4.54M 0.11% 178
2022
Q4
– Sell
-14,398
Closed -$259K – 1751
2022
Q3
$259K Buy
+14,398
New +$189K ﹤0.01% 1097

Centiva Capital's ISEE Position: Q3 2023 in Review

Centiva Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 128,544 shares — an estimated $5.06M sold.

Centiva Capital first reported a position in ISEE in Q3 2022 and held it in 2 quarters. The position peaked at $5.06M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Centiva Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Centiva Capital sold 128,544 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $5.06M.
  • Centiva Capital first reported a position in IVERIC bio, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Centiva Capital's IVERIC bio, Inc. Common Stock position peaked at $5.06M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.